Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Dr. Kaushik J. Dave, President and CEO of Actinium, will present at the Canaccord Genuity 34th Annual Growth Conference on Wednesday, August 13, 2014, at 9:30 a.m. ET in Boston, MA.
Help employers find you! Check out all the jobs and post your resume.
